Resources
For the latest in discovery & development, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Molecular Drug Design
New Trailblazer Profluent Launches its AI-enabled OpenCRISPR-1 to Edit the Human Genome
Profluent successfully combined large language models (LLMs) and CRISPR for an open-source AI gene editing project which could reshape CRISPR treatment options.
Beyond Traditional Therapeutics: How Digital Therapeutics Reshape Neurological and Neuropsychiatric Treatments
Two case studies show how digital therapeutics can potentially treat neurological and neuropsychiatric conditions, areas where conventional therapeutics have encountered obstacles.
Chemical Biology
From Screening to Success: How Molecular 'Super-Glue' SJ3149, Could Advance Cancer Treatments
Researchers at St Jude Children's Research Hospital used high throughput screening (HTS) to identify SJ3149, a molecular glue degrader. This small molecule demonstrated efficacy across a range of cancer types.
Molecular Drug Design
Novo Nordisk Foundation and NVIDIA to Launch a State-of-the-Art National AI Research Centre
Novo Nordisk and NVIDIA join forces to build an AI supercomputer which will be housed in Denmark's national centre for AI innovation.
Molecular Drug Design
AI-driven High Throughput Screening for Targeted Drug Discovery
Artificial Intelligence (AI) has significantly transformed high throughput screening (HTS) in drug discovery, increasing efficiency, accuracy, and predictive capabilities in early drug development stages. This research highlights AI's integration into HTS processes, showcasing improved outcomes in hit identification, assay optimization, and target validation, thus accelerating and refining the search for new medications.
Target Discovery
Post-Event Proceedings – Discovery Europe 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Discovery Europe 2023.
Automation
Post-Event Proceedings – Pharmaceutical Mobile Robotics 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Pharmaceutical Mobile Robotics 2023.
Automation
Post-Event Proceedings – SmartLabs Automation 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at SmartLabs Automation 2023.
eBook: Sustainability & Green Innovations in Pharma and Healthcare
Read how innovators are transforming the industry towards one that prioritizes both healthy patients and a healthy planet.
Molecular Drug Design
NeuralPLexer2 - Has AlphaFold2 Met Its Match?
Iambic Therapeutics’ protein structure predictive model, NeuralPLexer2, surpasses AlphaFold2’s abilities.
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery